乳腺癌原代细胞系-布瑞坎瑟（河北）生物科技有限公司

乳腺癌原代细胞系

Primary breast cancer cell line

您当前的位置：

了解我们

乳腺癌原代细胞系

乳腺癌原代细胞形态

组 7857@1x.jpg

细胞来源的乳腺癌患者临床病理特征

Clinicopathological status in 6 Cases of Patients with Breast Cancer

Cases Variables	Histological Type	Age	Menopausal status	Size of tumor (mm)	TNM	Pathological grade	Lymph node status	Metastasis (site)
BC3#	浸润性导管癌伴导管原位癌	68	Post-	28617	T2N2M0	III	Positive	Negative
BC4#	浸润性导管癌伴导管原位癌	45	Post-	403312	T2N0M0	I	Negative	Negative
BC5#	浸润性导管癌	44	Pre-	151419	T2N0M0	II	Negative	Negative
BC6#	浸润性导管癌	47	Pre-	361528	T4N0M0		Negative	Negative
BC10#	浸润性导管癌	46	Pre-	502939	T4N1M0	II	Positive	Negative
BC13#	浸润性导管癌	37	Pre-	261426	T2N1M0	II	Positive	Negative

细胞来源的乳腺癌患者分子标志物检测

The expression of molecular markers in 14 Cases of Patients with Breast Cancer

图片2.png

乳腺癌原代细胞STR

STR test results

	BC3#	BC4#	BC5#	BC6#	BC10#	BC13#
D19S433	12/12	12/12	12/12	12/12	12/12	12/12
D5S818	11/12	11/12	11/12	11/12	10/11/12/13	11/12
D21S11	29/29	28/29	28/29	28/29	28/29	28/29
D18S51	16/16	16/16	17/18	16/16	16/16	16/16
D6S1043	10/19	10/11/19	10/19	10/19	10/19	10/19
AMEL	XX	XX	XX	XX	XX	XX
D3S1358	14/15	14/16	14/16	14/16	14/15	14/16
D13S317	13/13	13/13	13/13	13/13	12/13	13/13
D7S820	10.1/11	10/11	10/11	10/12	9/10/11	10/12
D16S539	11/13	11/13	11/13	11/13	11/13	11/13
CSF1PO	11/11	12/12	12/12	11/12	12/13	11/12
Penta D	8/9	8/9	8/9	8/9	8/9	8/9
D2S441	11/13	11/12/13	11/13	11/13	11/13	11/13
vWA	16/17	16/16	16/16	16/16	16/16	16/16
D8S1179	15/17	15/17	15/17	17/17	15/17	15/17
TPOX	8/10	8/10	8/10	8/10	8/10	8/10
Penta E	9/12	9/13	9/13	9/13	9/13	9/13
TH01	6/6	6/6/19	6/6	6/6	6/6	6/6
D12S391	19/24	20	18/24	19/24	18/19/24	19/24
D2S1338	21/22	21/22	21/22	21/22	21/22	21/22
FGA	18/24	18/24	17/24	18/25	18/22/24	18/25